Research graph
References from The neurological burden of cirrhosis: a comprehensive clinical review of mechanisms, diagnosis, and management. Local targets link to admitted publications; unresolved targets remain external evidence.
Liver Cirrhosis: Evolving Definitions, and Recent Advances in Diagnosis, Prevention and Management
10.3390/livers5030028 · 2025 · External reference
Towards a new definition of decompensated cirrhosis
10.1016/j.jhep.2021.06.018 · 2022 · External reference
Decompensated liver cirrhosis
10.1016/j.mpaic.2020.12.011 · 2021 · External reference
Neurologic Manifestations of Chronic Liver Disease and Liver Cirrhosis
10.1067/j.cpradiol.2015.03.004 · 2015 · External reference
Recent Updates on Acquired Hepatocerebral Degeneration
10.7916/d8tb1k44 · 2017 · External reference
Management of Neurologic Manifestations in Patients with Liver Disease
10.1007/s11940-016-0419-0 · 2016 · External reference
Are acquired hepatocerebral degeneration and hepatic myelopathy reversible?
10.1097/mcg.0b013e318150d399 · 2009 · External reference
Cirrhosis-associated immune dysfunction
10.1038/s41575-021-00520-7 · 2022 · External reference
Low likelihood of intracranial hemorrhage in patients with cirrhosis and altered mental status
10.1016/j.cgh.2014.05.022 · 2015 · External reference
Overuse of Head Computed Tomography in Cirrhosis With Altered Mental Status
10.1016/j.amjms.2016.02.022 · 2016 · External reference
Hepatic Encephalopathy: Current and Emerging Treatment Modalities
10.1016/j.cgh.2022.04.034 · 2022 · External reference
European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the management of hepatic encephalopathy
10.1016/j.jhep.2022.06.001 · 2022 · External reference
Diagnosis and management of hepatic encephalopathy: The French recommendations
10.1111/liv.15510 · 2023 · External reference
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver
10.1002/hep.27210 · 2014 · External reference
Management of Stroke in Patients With Chronic Liver Disease: A Practical Review
10.1161/strokeaha.123.043011 · 2023 · External reference
Risk of Stroke in Liver Cirrhosis: A Systematic Review and Meta-Analysis
10.1097/mcg.0000000000001201 · 2020 · External reference
Cirrhosis and risk of stroke: A systematic review and meta-analysis
10.1016/j.atherosclerosis.2018.06.876 · 2018 · External reference
Muscle cramps in cirrhosis
10.1097/cld.0000000000000116 · 2024 · External reference
Treatment of Muscle Cramps in Patients With Cirrhosis of Liver: A Systematic Review
10.1016/j.jceh.2021.10.147 · 2022 · External reference
L-carnitine Reduces Muscle Cramps in Patients With Cirrhosis
10.1016/j.cgh.2014.12.005 · 2015 · External reference
Management of Muscle Cramps in Patients With Cirrhosis: A Systematic Review of Randomised Controlled Trials
10.1111/apt.18398 · 2025 · External reference
Sleep disturbances in patients with liver cirrhosis: prevalence, impact, and management challenges
10.2147/nss.s186665 · 2018 · External reference
Benzodiazepines and risk for hepatic encephalopathy in patients with cirrhosis and ascites
10.1177/2050640617727179 · 2018 · External reference
Why zolpidem increases the risk of falls and fractures in patients with cirrhosis
10.1016/j.jhepr.2022.100528 · 2022 · External reference
Epidemiology of Hepatic Encephalopathy
10.1016/j.cld.2020.01.001 · 2020 · External reference
Changing Epidemiology of Cirrhosis and Hepatic Encephalopathy
10.1016/j.cgh.2022.04.036 · 2022 · External reference
Hepatic Encephalopathy
10.1056/nejmra1600561 · 2016 · External reference
Hepatic encephalopathy
10.1038/s41572-022-00366-6 · 2022 · External reference
Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure
10.1016/j.jceh.2014.02.004 · 2015 · External reference
Cerebral edema and liver disease: Classic perspectives and contemporary hypotheses on mechanism
10.1016/j.neulet.2020.134818 · 2020 · External reference
Pathomechanisms in hepatic encephalopathy
10.1515/hsz-2021-0168 · 2021 · External reference
Effect of osmolality and anion channel inhibitors on myo-inositol efflux in cultured astrocytes
10.1002/(sici)1097-4547(19990915)57:6<866::aid-jnr12>3.0.co;2-k · 1999 · External reference
Cerebral water content mapping in cirrhosis patients with and without manifest HE
10.1007/s11011-019-00427-y · 2019 · External reference
Brain Edema in Chronic Hepatic Encephalopathy
10.1016/j.jceh.2019.02.003 · 2019 · External reference
Hepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology
10.1007/s40265-018-1017-0 · 2019 · External reference
Brain edema: a valid endpoint for measuring hepatic encephalopathy?
10.1007/s11011-016-9843-9 · 2016 · External reference
Osmotic and oxidative/nitrosative stress in ammonia toxicity and hepatic encephalopathy
10.1016/j.abb.2013.03.010 · 2013 · External reference
Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy
10.3748/wjg.v19.i1.26 · 2013 · External reference
Brain edema in acute liver failure and chronic liver disease: similarities and differences
10.1016/j.neuint.2013.01.015 · 2013 · External reference
Diagnosis and Management of Cirrhosis and Its Complications: A Review
10.1001/jama.2023.5997 · 2023 · External reference
Psychometric hepatic encephalopathy score (PHES)—when, how, why, and why not: a guide for the unfamiliar
10.5114/pg.2024.145382 · 2025 · External reference
Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy
10.1111/jgh.13283 · 2016 · External reference
Hepatic Encephalopathy: Definition, Clinical Grading and Diagnostic Principles
10.1007/s40265-018-1018-z · 2019 · External reference
Covert hepatic encephalopathy: not as minimal as you might think
10.1016/j.cgh.2012.05.026 · 2012 · External reference
Sleep and liver disease: a bidirectional relationship
10.1016/s2468-1253(21)00169-2 · 2021 · External reference
Review article: the modern management of hepatic encephalopathy
10.1111/j.1365-2036.2009.04211.x · 2010 · External reference
Diagnosis of covert hepatic encephalopathy: a multi-center study testing the utility of single versus combined testing
10.1007/s11011-018-0350-z · 2019 · External reference
Electro-Radiological Observations of Grade III/IV Hepatic Encephalopathy Patients with Seizures
10.1007/s12028-017-0435-2 · 2018 · External reference
Liver disease severity is poorly related to the presence of restless leg syndrome in patients with cirrhosis
10.4103/0028-3886.263171 · 2019 · External reference
High prevalence of neuropathies in patients with end-stage liver disease
10.1111/j.1600-0404.2009.01256.x · 2010 · External reference
Brain surgery in patients with liver cirrhosis
10.3171/2012.4.jns111338 · 2012 · External reference
National Early Warning Score Accurately Discriminates the Risk of Serious Adverse Events in Patients With Liver Disease
10.1016/j.cgh.2017.12.035 · 2018 · External reference
CLIF-SOFA and CLIF-C scores for the prognostication of acute-on-chronic liver failure and acute decompensation of cirrhosis: A systematic review
10.4254/wjh.v14.i12.2025 · 2022 · External reference
A practical approach to the diagnosis and management of hepatic encephalopathy
10.1016/j.amjmed.2025.08.041 · 2026 · External reference
Ammonia and the Muscle: An Emerging Point of View on Hepatic Encephalopathy
10.3390/jcm11030611 · 2022 · External reference
Nutritional Management in Liver Cirrhosis: A Combined Systematic Review and Observational Study
10.3390/diseases13090278 · 2025 · External reference
Nutrition in Patients With Cirrhosis
2019 · External reference
Current approaches to hepatic encephalopathy
10.1016/j.aohep.2022.100757 · 2022 · External reference
Hepatic Encephalopathy and Treatment Modalities: A Review Article
10.7759/cureus.28016 · 2022 · External reference
Rifaximin treatment in hepatic encephalopathy
10.1056/nejmoa0907893 · 2010 · External reference
Pharmacokinetic and Pharmacodynamic Properties of L-Ornithine L-Aspartate (LOLA) in Hepatic Encephalopathy
10.1007/s40265-018-1023-2 · 2019 · External reference
Oral branched-chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with meta-analyses of randomized controlled trials
10.3945/jn.113.174375 · 2013 · External reference
Albumin in decompensated cirrhosis: new concepts and perspectives
10.1136/gutjnl-2019-318843 · 2020 · External reference
Revisiting cirrhosis-related parkinsonism: a comprehensive review
10.1007/s11011-026-01875-z · 2026 · External reference
Parkinsonism in cirrhosis: pathogenesis and current therapeutic options
10.1007/s11011-012-9341-7 · 2013 · External reference
Acquired chronic hepatocerebral degeneration (CAHD)—Simulation of parkinsonism, secondary to chronic liver disease
10.17235/reed.2024.10535/2024 · 2025 · External reference
A double-blind randomized controlled trial to assess efficacy of bromocriptine in cirrhotic patients with hepatic parkinsonism
10.1111/liv.14024 · 2019 · External reference
Manganese homeostasis in the nervous system
10.1111/jnc.13170 · 2015 · External reference
Untangling the Manganese-α-Synuclein Web
10.3389/fnins.2016.00364 · 2016 · External reference
Metals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercury
10.1016/j.neuint.2012.12.006 · 2013 · External reference
Manganese, a Likely Cause of ‘Parkinson’s in Cirrhosis’, a Unique Clinical Entity of Acquired Hepatocerebral Degeneration
10.7759/cureus.10448 · 2020 · External reference
Manganese toxicity in the central nervous system: the glutamine/glutamate-γ-aminobutyric acid cycle
10.1111/joim.12040 · 2013 · External reference
Manganese activates NLRP3 inflammasome signaling and propagates exosomal release of ASC in microglial cells
10.1126/scisignal.aat9900 · 2019 · External reference
α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson’s disease
10.1093/toxsci/kfu247 · 2015 · External reference
Oxidative stress involvement in manganese-induced alpha-synuclein oligomerization in organotypic brain slice cultures
10.1016/j.tox.2013.01.006 · 2013 · External reference
Alpha-synuclein oligomerization in manganese-induced nerve cell injury in brain slices: a role of NO-mediated S-nitrosylation of protein disulfide isomerase
10.1007/s12035-014-8711-z · 2014 · External reference
Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration
10.1001/archneur.60.4.521 · 2003 · External reference
Chronic acquired hepatocerebral degeneration: case reports and new insights
10.1002/mds.870100604 · 1995 · External reference
Hepatic dementia or acquired hepatocerebral degeneration
10.1111/j.1532-5415.1989.tb06817.x · 1989 · External reference
Neuropsychiatric symptoms as the presenting feature of acquired hepatocerebral degeneration
10.1177/0004867414531079 · 2014 · External reference
Chronic acquired hepatocerebral degeneration, pallidal T1 MRI hyperintensity and manganese in a series of cirrhotic patients
10.1007/s10072-013-1458-x · 2014 · External reference
Changes in blood manganese concentration and MRI t1 relaxation time during 180 days of stainless steel welding-fume exposure in cynomolgus monkeys
10.1080/08958370600985834 · 2007 · External reference
MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: results of a controlled prospective clinical investigation
10.1016/s0168-8278(97)80290-5 · 1997 · External reference
10.1016/j.neuro.2017.02.014
10.1016/j.neuro.2017.02.014 · 2018 · External reference
Distribution of cerebral lesions in acquired hepatocerebral degeneration
10.1093/brain/104.1.79 · 1981 · External reference
Acquired hepatocerebral degeneration in a liver transplant recipient
10.1007/bf00294467 · 1995 · External reference
Reversal of acquired hepatocerebral degeneration with living donor liver transplantation
10.1002/lt.24306 · 2016 · External reference
A Prospective Study of the Prevalence of Parkinsonism in Patients With Liver Cirrhosis
10.1002/hep4.1624 · 2020 · External reference
Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation
10.1002/hep.26972 · 2014 · External reference
Long-term clinical and radiological improvement of chronic acquired hepatocerebral degeneration after obliteration of portosystemic shunt: Report of a case
10.1016/j.jns.2014.07.068 · 2014 · External reference
Effect of trientine on manganese intoxication in a patient with acquired hepatocerebral degeneration
10.1002/mds.21957 · 2008 · External reference
Evidence-based clinical practice guidelines for liver cirrhosis 2015
10.1007/s00535-016-1216-y · 2016 · External reference
Management of surgical splenorenal shunt-related hepatic myelopathy with endovascular interventional techniques
10.3748/wjg.v18.i47.7104 · 2012 · External reference
Hepatic encephalomyelopathy: a complication following liver cirrhosis caused by Budd-Chiari syndrome and HBV
10.3855/jidc.3052 · 2014 · External reference
Liver Transplantation Reverses Hepatic Myelopathy in 2 Children With Hepatitis A Infection
10.1177/2329048x20983763 · 2021 · External reference
[Analysis of clinical characteristics, prognosis, and influencing factors of hepatic myelopathy]
10.3760/cma.j.cn112137-20240704-01512 · 2025 · External reference
Hepatic Myelopathy: A Rare Complication of Chronic Liver Failure Treated Conservatively Without Liver Transplantation
10.7326/aimcc.2024.0940 · 2025 · External reference
Spastic paraparesis associated with advanced liver cirrhosis: a condition obscure in terms of treatment and prognosis
10.1136/bcr-2020-235090 · 2020 · External reference
Brain white matter fiber tracts involved in post-transjugular intrahepatic portosystemic shunt hepatic myelopathy
10.1097/wnr.0000000000000898 · 2017 · External reference
Motor Cortex Mapping in Patients With Hepatic Myelopathy After Transjugular Intrahepatic Portosystemic Shunt
10.1016/j.acra.2018.06.013 · 2019 · External reference
Shunt encephalomyelopathy. II. Occurrence of permanent myelopathy
10.7326/0003-4819-53-1-53 · 1960 · External reference
Hepatic myelopathy neurological complication of chronic liver disease: two case reports
10.1186/s13256-024-04495-2 · 2024 · External reference
Hepatic myelopathy with spastic paraparesis: report of two cases and review of the literature
10.1007/s00586-013-2828-z · 2014 · External reference
Hepatic myelopathy with spastic paraparesis
10.1016/j.clineuro.2004.10.002 · 2005 · External reference
Hepatic myelopathy: an unusual neurological complication of chronic liver disease presenting as quadriparesis
10.1136/bcr-2013-009078 · 2013 · External reference
Neurologic Manifestations of Hepatic and Gastrointestinal Disease
10.1212/cont.0000000000001666 · 2026 · External reference
Hepatic Myelopathy: Case Report of an Unusual MRI Finding
10.3174/ng.1700019 · 2018 · External reference
Corticospinal involvement in patients with a portosystemic shunt due to liver cirrhosis: a MEP study
10.1007/s00415-005-0930-9 · 2006 · External reference
Spontaneous remission of hepatic myelopathy in a patient with alcoholic cirrhosis: A case report
10.12998/wjcc.v10.i30.11172 · 2022 · External reference
Hepatic myelopathy improved by embolization of spontaneous portosystemic shunt and partial splenic artery embolization—Literature review
10.17235/reed.2025.11451/2025 · 2026 · External reference
Partial splenic artery embolization for severe hepatic myelopathy in cirrhosis
10.1002/hep.29597 · 2018 · External reference
The effect of fecal microbiota transplantation on Hepatic myelopathy: A case report
10.1097/md.0000000000016430 · 2019 · External reference
Liver Transplantation Reverses Hepatic Myelopathy in the Decompensated Phase of Cirrhosis: Case Report and Literature Review
10.14218/jcth.2023.00487 · 2024 · External reference
Peripheral neuropathy in chronic liver disease: clinical, electrodiagnostic, and nerve biopsy findings
10.1136/jnnp.35.1.22 · 1972 · External reference
Autonomic and peripheral (sensorimotor) neuropathy in chronic liver disease: a clinical and electrophysiologic study
10.1002/hep.510290630 · 1999 · External reference
Alcohol-Induced Neuropathy in Chronic Alcoholism: Causes, Pathophysiology, Diagnosis, and Treatment Options
10.1007/s40139-020-00214-w · 2020 · External reference
Alcohol-related peripheral neuropathy: a systematic review and meta-analysis
10.1007/s00415-018-9123-1 · 2019 · External reference
Value of nerve biopsy in the management of peripheral neuropathies
10.1080/14737175.2018.1489240 · 2018 · External reference
Why Do Individuals with Cirrhosis Fall? A Mechanistic Model for Fall Assessment, Treatment, and Research
10.1007/s10620-018-5333-8 · 2019 · External reference
Comparing Frequency of Cardiovascular Autonomic Neuropathy in Diabetic Cirrhotic with Non-Diabetic Cirrhotic Patients
10.54393/pbmj.v5i1.169 · 2022 · External reference
Acrocyanosis A Manifestation of Autonomic Dysfunction in Chronic Liver Disease-Case Report
10.47363/jghr/2022(3)136 · 2022 · External reference
The predictive role of autonomic neuropathy in pre- and post-liver transplantation outcomes: a systematic review and meta-analysis
10.20524/aog.2024.0905 · 2024 · External reference
Autonomic neuropathy in patients with hepatic cirrhosis
10.1136/pmj.79.933.408 · 2003 · External reference
The role of autonomic dysfunction in cirrhotic patients before and after liver transplantation. Review of the literature
10.1111/liv.13126 · 2016 · External reference
Relation between the severity of liver cirrhosis and neurological symptoms, nerve conduction study results, and motor unit number estimation
10.1111/jvh.13552 · 2021 · External reference
Autonomic neuropathy in liver cirrhosis: relationship with alcoholic aetiology and severity of the disease
1994 · External reference
Autonomic and sensory nerve dysfunction in primary biliary cirrhosis
10.3748/wjg.v10.i20.3039 · 2004 · External reference
Contemporary management of pain in cirrhosis: Toward precision therapy for pain
10.1002/hep.32598 · 2023 · External reference
Autonomic neuropathy in end-stage cirrhotic patients and evolution after liver transplantation
10.1016/s0041-1345(03)00587-6 · 2003 · External reference
Intracerebral Hemorrhage
10.1159/000542566 · 2025 · External reference
Spontaneous intracranial hemorrhage in cirrhotic patients
10.1016/j.clineuro.2007.11.010 · 2008 · External reference
The pathophysiology of thrombocytopenia in chronic liver disease
10.2147/hmer.s74612 · 2016 · External reference
Haemostatic Profiles are Similar across All Aetiologies of Cirrhosis
10.1055/s-0038-1676954 · 2019 · External reference
Diagnostic Performance of Noninvasive Tests for Identifying Advanced Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease With Mixed Etiologies
10.1016/j.eprac.2025.04.021 · 2025 · External reference
Intracerebral hemorrhage in patients with chronic liver disease
10.2176/nmc.52.181 · 2012 · External reference
Increased risk of subdural hematoma in patients with liver cirrhosis
10.1093/qjmed/hcx167 · 2017 · External reference
Flow, Liver, Flow: A Retrospective Analysis of the Interplay of Liver Disease and Coagulopathy in Chronic Subdural Hematoma
10.1016/j.wneu.2017.03.014 · 2017 · External reference
Retrospective Analysis of Risk Factors for Recurrent Chronic Subdural Hematoma
10.21129/nerve.2016.2.2.54 · 2016 · External reference
Delayed Onset Acute Subdural Hematoma after Burr Hole Drainage in a Patient with Chronic Subdural Hematoma and Liver Cirrhosis
10.13004/kjnt.2021.17.e15 · 2021 · External reference
Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?
10.1161/jaha.116.005307 · 2017 · External reference
Atrial fibrillation, liver disease, antithrombotics and risk of cerebrovascular events: A population-based cohort study
10.1016/j.ijcard.2016.08.297 · 2016 · External reference
Cirrhosis patients’ stroke risks and adverse outcomes: Two nationwide studies
10.1016/j.atherosclerosis.2017.05.030 · 2017 · External reference
Discharge Disposition After Stroke in Patients With Liver Disease
10.1161/strokeaha.116.016016 · 2017 · External reference
Prothrombin Complex Concentrate Use in Intracranial Hemorrhage Patients With Cirrhosis Not on Prior Anticoagulation
10.1177/08850666211012650 · 2022 · External reference
Management of bacterial and fungal infections in cirrhosis: The MDRO challenge
10.1016/j.jhep.2020.11.010 · 2021 · External reference
The Evolving Challenge of Infections in Cirrhosis
10.1056/nejmra2021808 · 2021 · External reference
Infections in cirrhosis
10.1016/s2468-1253(24)00078-5 · 2024 · External reference
Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance
10.1016/j.jhep.2014.08.010 · 2014 · External reference
Infections in Cirrhosis: A Guide for the Clinician
10.1016/j.amjmed.2021.01.015 · 2021 · External reference
Infections in Cirrhosis
10.1007/s11938-019-00229-2 · 2019 · External reference
Community-acquired bacterial meningitis in cirrhotic patients
10.1111/j.1469-0691.2007.01839.x · 2008 · External reference
Multiple cerebral abscesses in decompensated cirrhosis of liver as a mimicker of hepatic encephalopathy: A case report
10.32677/ijcr.2018.v04.i04.017 · 2018 · External reference
Intracranial invasive mycosis mimicking hepatic encephalopathy in a patient with cirrhosis
10.1136/bcr-2019-231548 · 2019 · External reference
A Mimic of Hepatic Encephalopathy: Two Cases of Cryptococcal Meningitis in North America
10.14218/jcth.2019.00005 · 2019 · External reference
Increased occurrence of brain abscesses in cirrhotic patients: A population-based 3-year follow-up study
10.5152/tjg.2017.6374 · 2017 · External reference
Bacterial meningitis complicating the course of liver cirrhosis
10.1007/s15010-017-1039-7 · 2017 · External reference
Bacterial Meningitis Associated With Spontaneous Bacterial Peritonitis Caused by Escherichia coli in a Patient With Alcoholic Liver Cirrhosis
10.7759/cureus.77937 · 2025 · External reference
Brain abscess following endoscopic ligation of esophageal varicose veins
10.1007/s00701-009-0539-3 · 2010 · External reference
Pathogenesis, diagnosis and therapy of Infections complicating patients with chronic liver disease
2003 · External reference
Supratentorial
10.4103/aian.aian_233_18 · 2020 · External reference
Prevalence of cryptococcal antigenemia in hospitalized patients with liver cirrhosis
10.1093/mmy/myz045 · 2020 · External reference
Disseminated cryptococcosis in HIV-uninfected patients
10.1007/s10096-007-0430-1 · 2008 · External reference
Meningitis Caused by Candida Dubliniensis in a Patient with Cirrhosis: A Case Report and Review of the Literature
10.1007/s11046-016-0006-7 · 2016 · External reference
Multiple Brain Abscesses Due to Aspergillus Fumigatus in a Patient With Liver Cirrhosis: A Case Report
10.1097/md.0000000000002813 · 2016 · External reference
Isolated brain abscess caused by Aspergillus tubingensis in a patient with alcoholic liver cirrhosis
10.1016/j.jiac.2025.102691 · 2025 · External reference
Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial
10.1002/hep.29306 · 2017 · External reference
Comprehensive Overview of Sleep Disorders in Patients with Chronic Liver Disease
10.3390/brainsci11020142 · 2021 · External reference
Sleep-wake abnormalities in patients with cirrhosis
10.1002/hep.26555 · 2014 · External reference
Frailty and Sleep Disorder in Chronic Liver Diseases
10.3390/life10080137 · 2020 · External reference
Assessment and Management of Sleep Disturbance in Cirrhosis
10.1007/s11901-018-0390-1 · 2018 · External reference
Sleep disorders in cirrhotics; how can we detect?
10.1111/liv.12485 · 2014 · External reference
Restless legs syndrome among subjects having chronic liver disease: A systematic review and meta-analysis
10.1016/j.smrv.2021.101463 · 2021 · External reference
Restless Leg Syndrome and Liver Cirrhosis: is it common?
2019 · External reference
Decreased serum hepcidin concentration correlates with brain iron deposition in patients with HBV-related cirrhosis
10.1371/journal.pone.0065551 · 2013 · External reference
Restless leg syndrome in patients with liver cirrhosis: Waiting for the shoe to drop
10.4103/0028-3886.263218 · 2019 · External reference
Prevalence, severity, and impact on quality of life of restless leg syndrome in patients with liver cirrhosis in India
10.1007/s12664-016-0668-6 · 2016 · External reference
Management of restless legs syndrome in chronic liver disease: A challenge for the correct diagnosis and therapy
10.4254/wjh.v10.i3.379 · 2018 · External reference
Prevalence and morbidity associated with muscle cramps in patients with cirrhosis
10.1016/j.amjmed.2012.03.012 · 2012 · External reference
Pickle Juice Intervention for Cirrhotic Cramps Reduction: The PICCLES Randomized Controlled Trial
10.14309/ajg.0000000000001781 · 2022 · External reference
Reflex inhibition of electrically induced muscle cramps in hypohydrated humans
10.1249/mss.0b013e3181c0647e · 2010 · External reference
Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration
10.1001/archneur.60.4.521 · ExternalCitation · doi-reference
Diagnosis and Management of Cirrhosis and Its Complications: A Review
10.1001/jama.2023.5997 · ExternalCitation · doi-reference
Effect of osmolality and anion channel inhibitors on myo-inositol efflux in cultured astrocytes
10.1002/(sici)1097-4547(19990915)57:6<866::aid-jnr12>3.0.co;2-k · ExternalCitation · doi-reference
Sleep-wake abnormalities in patients with cirrhosis
10.1002/hep.26555 · ExternalCitation · doi-reference
Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation
10.1002/hep.26972 · ExternalCitation · doi-reference
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver
10.1002/hep.27210 · ExternalCitation · doi-reference
Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial
10.1002/hep.29306 · ExternalCitation · doi-reference
Partial splenic artery embolization for severe hepatic myelopathy in cirrhosis
10.1002/hep.29597 · ExternalCitation · doi-reference
Contemporary management of pain in cirrhosis: Toward precision therapy for pain
10.1002/hep.32598 · ExternalCitation · doi-reference
Autonomic and peripheral (sensorimotor) neuropathy in chronic liver disease: a clinical and electrophysiologic study
10.1002/hep.510290630 · ExternalCitation · doi-reference
A Prospective Study of the Prevalence of Parkinsonism in Patients With Liver Cirrhosis
10.1002/hep4.1624 · ExternalCitation · doi-reference
Reversal of acquired hepatocerebral degeneration with living donor liver transplantation
10.1002/lt.24306 · ExternalCitation · doi-reference
Effect of trientine on manganese intoxication in a patient with acquired hepatocerebral degeneration
10.1002/mds.21957 · ExternalCitation · doi-reference
Chronic acquired hepatocerebral degeneration: case reports and new insights
10.1002/mds.870100604 · ExternalCitation · doi-reference
Acquired hepatocerebral degeneration in a liver transplant recipient
10.1007/bf00294467 · ExternalCitation · doi-reference
Corticospinal involvement in patients with a portosystemic shunt due to liver cirrhosis: a MEP study
10.1007/s00415-005-0930-9 · ExternalCitation · doi-reference
Alcohol-related peripheral neuropathy: a systematic review and meta-analysis
10.1007/s00415-018-9123-1 · ExternalCitation · doi-reference
Evidence-based clinical practice guidelines for liver cirrhosis 2015
10.1007/s00535-016-1216-y · ExternalCitation · doi-reference
Hepatic myelopathy with spastic paraparesis: report of two cases and review of the literature
10.1007/s00586-013-2828-z · ExternalCitation · doi-reference
Brain abscess following endoscopic ligation of esophageal varicose veins
10.1007/s00701-009-0539-3 · ExternalCitation · doi-reference
Chronic acquired hepatocerebral degeneration, pallidal T1 MRI hyperintensity and manganese in a series of cirrhotic patients
10.1007/s10072-013-1458-x · ExternalCitation · doi-reference
Disseminated cryptococcosis in HIV-uninfected patients
10.1007/s10096-007-0430-1 · ExternalCitation · doi-reference
Why Do Individuals with Cirrhosis Fall? A Mechanistic Model for Fall Assessment, Treatment, and Research
10.1007/s10620-018-5333-8 · ExternalCitation · doi-reference
Parkinsonism in cirrhosis: pathogenesis and current therapeutic options
10.1007/s11011-012-9341-7 · ExternalCitation · doi-reference
Brain edema: a valid endpoint for measuring hepatic encephalopathy?
10.1007/s11011-016-9843-9 · ExternalCitation · doi-reference
Diagnosis of covert hepatic encephalopathy: a multi-center study testing the utility of single versus combined testing
10.1007/s11011-018-0350-z · ExternalCitation · doi-reference
Cerebral water content mapping in cirrhosis patients with and without manifest HE
10.1007/s11011-019-00427-y · ExternalCitation · doi-reference
Revisiting cirrhosis-related parkinsonism: a comprehensive review
10.1007/s11011-026-01875-z · ExternalCitation · doi-reference
Meningitis Caused by Candida Dubliniensis in a Patient with Cirrhosis: A Case Report and Review of the Literature
10.1007/s11046-016-0006-7 · ExternalCitation · doi-reference
Assessment and Management of Sleep Disturbance in Cirrhosis
10.1007/s11901-018-0390-1 · ExternalCitation · doi-reference
Infections in Cirrhosis
10.1007/s11938-019-00229-2 · ExternalCitation · doi-reference
Management of Neurologic Manifestations in Patients with Liver Disease
10.1007/s11940-016-0419-0 · ExternalCitation · doi-reference
Electro-Radiological Observations of Grade III/IV Hepatic Encephalopathy Patients with Seizures
10.1007/s12028-017-0435-2 · ExternalCitation · doi-reference
Alpha-synuclein oligomerization in manganese-induced nerve cell injury in brain slices: a role of NO-mediated S-nitrosylation of protein disulfide isomerase
10.1007/s12035-014-8711-z · ExternalCitation · doi-reference
Prevalence, severity, and impact on quality of life of restless leg syndrome in patients with liver cirrhosis in India
10.1007/s12664-016-0668-6 · ExternalCitation · doi-reference
Bacterial meningitis complicating the course of liver cirrhosis
10.1007/s15010-017-1039-7 · ExternalCitation · doi-reference
Alcohol-Induced Neuropathy in Chronic Alcoholism: Causes, Pathophysiology, Diagnosis, and Treatment Options
10.1007/s40139-020-00214-w · ExternalCitation · doi-reference
Hepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology
10.1007/s40265-018-1017-0 · ExternalCitation · doi-reference
Hepatic Encephalopathy: Definition, Clinical Grading and Diagnostic Principles
10.1007/s40265-018-1018-z · ExternalCitation · doi-reference
Pharmacokinetic and Pharmacodynamic Properties of L-Ornithine L-Aspartate (LOLA) in Hepatic Encephalopathy
10.1007/s40265-018-1023-2 · ExternalCitation · doi-reference
Osmotic and oxidative/nitrosative stress in ammonia toxicity and hepatic encephalopathy
10.1016/j.abb.2013.03.010 · ExternalCitation · doi-reference
Motor Cortex Mapping in Patients With Hepatic Myelopathy After Transjugular Intrahepatic Portosystemic Shunt
10.1016/j.acra.2018.06.013 · ExternalCitation · doi-reference
Prevalence and morbidity associated with muscle cramps in patients with cirrhosis
10.1016/j.amjmed.2012.03.012 · ExternalCitation · doi-reference
Infections in Cirrhosis: A Guide for the Clinician
10.1016/j.amjmed.2021.01.015 · ExternalCitation · doi-reference
A practical approach to the diagnosis and management of hepatic encephalopathy
10.1016/j.amjmed.2025.08.041 · ExternalCitation · doi-reference
Overuse of Head Computed Tomography in Cirrhosis With Altered Mental Status
10.1016/j.amjms.2016.02.022 · ExternalCitation · doi-reference
Current approaches to hepatic encephalopathy
10.1016/j.aohep.2022.100757 · ExternalCitation · doi-reference
Cirrhosis patients’ stroke risks and adverse outcomes: Two nationwide studies
10.1016/j.atherosclerosis.2017.05.030 · ExternalCitation · doi-reference
Cirrhosis and risk of stroke: A systematic review and meta-analysis
10.1016/j.atherosclerosis.2018.06.876 · ExternalCitation · doi-reference
Covert hepatic encephalopathy: not as minimal as you might think
10.1016/j.cgh.2012.05.026 · ExternalCitation · doi-reference
Low likelihood of intracranial hemorrhage in patients with cirrhosis and altered mental status
10.1016/j.cgh.2014.05.022 · ExternalCitation · doi-reference
L-carnitine Reduces Muscle Cramps in Patients With Cirrhosis
10.1016/j.cgh.2014.12.005 · ExternalCitation · doi-reference
National Early Warning Score Accurately Discriminates the Risk of Serious Adverse Events in Patients With Liver Disease
10.1016/j.cgh.2017.12.035 · ExternalCitation · doi-reference
Hepatic Encephalopathy: Current and Emerging Treatment Modalities
10.1016/j.cgh.2022.04.034 · ExternalCitation · doi-reference
Changing Epidemiology of Cirrhosis and Hepatic Encephalopathy
10.1016/j.cgh.2022.04.036 · ExternalCitation · doi-reference
Epidemiology of Hepatic Encephalopathy
10.1016/j.cld.2020.01.001 · ExternalCitation · doi-reference
Hepatic myelopathy with spastic paraparesis
10.1016/j.clineuro.2004.10.002 · ExternalCitation · doi-reference
Spontaneous intracranial hemorrhage in cirrhotic patients
10.1016/j.clineuro.2007.11.010 · ExternalCitation · doi-reference
Diagnostic Performance of Noninvasive Tests for Identifying Advanced Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease With Mixed Etiologies
10.1016/j.eprac.2025.04.021 · ExternalCitation · doi-reference
Atrial fibrillation, liver disease, antithrombotics and risk of cerebrovascular events: A population-based cohort study
10.1016/j.ijcard.2016.08.297 · ExternalCitation · doi-reference
Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure
10.1016/j.jceh.2014.02.004 · ExternalCitation · doi-reference
Brain Edema in Chronic Hepatic Encephalopathy
10.1016/j.jceh.2019.02.003 · ExternalCitation · doi-reference
Treatment of Muscle Cramps in Patients With Cirrhosis of Liver: A Systematic Review
10.1016/j.jceh.2021.10.147 · ExternalCitation · doi-reference
Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance
10.1016/j.jhep.2014.08.010 · ExternalCitation · doi-reference
Management of bacterial and fungal infections in cirrhosis: The MDRO challenge
10.1016/j.jhep.2020.11.010 · ExternalCitation · doi-reference
Towards a new definition of decompensated cirrhosis
10.1016/j.jhep.2021.06.018 · ExternalCitation · doi-reference
European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the management of hepatic encephalopathy
10.1016/j.jhep.2022.06.001 · ExternalCitation · doi-reference
Why zolpidem increases the risk of falls and fractures in patients with cirrhosis
10.1016/j.jhepr.2022.100528 · ExternalCitation · doi-reference
Isolated brain abscess caused by Aspergillus tubingensis in a patient with alcoholic liver cirrhosis
10.1016/j.jiac.2025.102691 · ExternalCitation · doi-reference
Long-term clinical and radiological improvement of chronic acquired hepatocerebral degeneration after obliteration of portosystemic shunt: Report of a case
10.1016/j.jns.2014.07.068 · ExternalCitation · doi-reference
Decompensated liver cirrhosis
10.1016/j.mpaic.2020.12.011 · ExternalCitation · doi-reference
Metals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercury
10.1016/j.neuint.2012.12.006 · ExternalCitation · doi-reference
Brain edema in acute liver failure and chronic liver disease: similarities and differences
10.1016/j.neuint.2013.01.015 · ExternalCitation · doi-reference
Cerebral edema and liver disease: Classic perspectives and contemporary hypotheses on mechanism
10.1016/j.neulet.2020.134818 · ExternalCitation · doi-reference
10.1016/j.neuro.2017.02.014
10.1016/j.neuro.2017.02.014 · ExternalCitation · doi-reference
Restless legs syndrome among subjects having chronic liver disease: A systematic review and meta-analysis
10.1016/j.smrv.2021.101463 · ExternalCitation · doi-reference
Oxidative stress involvement in manganese-induced alpha-synuclein oligomerization in organotypic brain slice cultures
10.1016/j.tox.2013.01.006 · ExternalCitation · doi-reference
Flow, Liver, Flow: A Retrospective Analysis of the Interplay of Liver Disease and Coagulopathy in Chronic Subdural Hematoma
10.1016/j.wneu.2017.03.014 · ExternalCitation · doi-reference
Autonomic neuropathy in end-stage cirrhotic patients and evolution after liver transplantation
10.1016/s0041-1345(03)00587-6 · ExternalCitation · doi-reference
MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: results of a controlled prospective clinical investigation
10.1016/s0168-8278(97)80290-5 · ExternalCitation · doi-reference
Sleep and liver disease: a bidirectional relationship
10.1016/s2468-1253(21)00169-2 · ExternalCitation · doi-reference
Infections in cirrhosis
10.1016/s2468-1253(24)00078-5 · ExternalCitation · doi-reference
Hepatic encephalopathy
10.1038/s41572-022-00366-6 · ExternalCitation · doi-reference
Cirrhosis-associated immune dysfunction
10.1038/s41575-021-00520-7 · ExternalCitation · doi-reference
Haemostatic Profiles are Similar across All Aetiologies of Cirrhosis
10.1055/s-0038-1676954 · ExternalCitation · doi-reference
Rifaximin treatment in hepatic encephalopathy
10.1056/nejmoa0907893 · ExternalCitation · doi-reference
Hepatic Encephalopathy
10.1056/nejmra1600561 · ExternalCitation · doi-reference
The Evolving Challenge of Infections in Cirrhosis
10.1056/nejmra2021808 · ExternalCitation · doi-reference
Neurologic Manifestations of Chronic Liver Disease and Liver Cirrhosis
10.1067/j.cpradiol.2015.03.004 · ExternalCitation · doi-reference
Changes in blood manganese concentration and MRI t1 relaxation time during 180 days of stainless steel welding-fume exposure in cynomolgus monkeys
10.1080/08958370600985834 · ExternalCitation · doi-reference
Value of nerve biopsy in the management of peripheral neuropathies
10.1080/14737175.2018.1489240 · ExternalCitation · doi-reference
Distribution of cerebral lesions in acquired hepatocerebral degeneration
10.1093/brain/104.1.79 · ExternalCitation · doi-reference
Prevalence of cryptococcal antigenemia in hospitalized patients with liver cirrhosis
10.1093/mmy/myz045 · ExternalCitation · doi-reference
Increased risk of subdural hematoma in patients with liver cirrhosis
10.1093/qjmed/hcx167 · ExternalCitation · doi-reference
α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson’s disease
10.1093/toxsci/kfu247 · ExternalCitation · doi-reference
Muscle cramps in cirrhosis
10.1097/cld.0000000000000116 · ExternalCitation · doi-reference
Risk of Stroke in Liver Cirrhosis: A Systematic Review and Meta-Analysis
10.1097/mcg.0000000000001201 · ExternalCitation · doi-reference
Are acquired hepatocerebral degeneration and hepatic myelopathy reversible?
10.1097/mcg.0b013e318150d399 · ExternalCitation · doi-reference
Multiple Brain Abscesses Due to Aspergillus Fumigatus in a Patient With Liver Cirrhosis: A Case Report
10.1097/md.0000000000002813 · ExternalCitation · doi-reference
The effect of fecal microbiota transplantation on Hepatic myelopathy: A case report
10.1097/md.0000000000016430 · ExternalCitation · doi-reference
Brain white matter fiber tracts involved in post-transjugular intrahepatic portosystemic shunt hepatic myelopathy
10.1097/wnr.0000000000000898 · ExternalCitation · doi-reference
Management of Muscle Cramps in Patients With Cirrhosis: A Systematic Review of Randomised Controlled Trials
10.1111/apt.18398 · ExternalCitation · doi-reference
Review article: the modern management of hepatic encephalopathy
10.1111/j.1365-2036.2009.04211.x · ExternalCitation · doi-reference
Community-acquired bacterial meningitis in cirrhotic patients
10.1111/j.1469-0691.2007.01839.x · ExternalCitation · doi-reference
Hepatic dementia or acquired hepatocerebral degeneration
10.1111/j.1532-5415.1989.tb06817.x · ExternalCitation · doi-reference
High prevalence of neuropathies in patients with end-stage liver disease
10.1111/j.1600-0404.2009.01256.x · ExternalCitation · doi-reference
Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy
10.1111/jgh.13283 · ExternalCitation · doi-reference
Manganese homeostasis in the nervous system
10.1111/jnc.13170 · ExternalCitation · doi-reference
Manganese toxicity in the central nervous system: the glutamine/glutamate-γ-aminobutyric acid cycle
10.1111/joim.12040 · ExternalCitation · doi-reference
Relation between the severity of liver cirrhosis and neurological symptoms, nerve conduction study results, and motor unit number estimation
10.1111/jvh.13552 · ExternalCitation · doi-reference
Sleep disorders in cirrhotics; how can we detect?
10.1111/liv.12485 · ExternalCitation · doi-reference
The role of autonomic dysfunction in cirrhotic patients before and after liver transplantation. Review of the literature
10.1111/liv.13126 · ExternalCitation · doi-reference
A double-blind randomized controlled trial to assess efficacy of bromocriptine in cirrhotic patients with hepatic parkinsonism
10.1111/liv.14024 · ExternalCitation · doi-reference
Diagnosis and management of hepatic encephalopathy: The French recommendations
10.1111/liv.15510 · ExternalCitation · doi-reference
Manganese activates NLRP3 inflammasome signaling and propagates exosomal release of ASC in microglial cells
10.1126/scisignal.aat9900 · ExternalCitation · doi-reference
Hepatic myelopathy: an unusual neurological complication of chronic liver disease presenting as quadriparesis
10.1136/bcr-2013-009078 · ExternalCitation · doi-reference
Intracranial invasive mycosis mimicking hepatic encephalopathy in a patient with cirrhosis
10.1136/bcr-2019-231548 · ExternalCitation · doi-reference
Spastic paraparesis associated with advanced liver cirrhosis: a condition obscure in terms of treatment and prognosis
10.1136/bcr-2020-235090 · ExternalCitation · doi-reference
Albumin in decompensated cirrhosis: new concepts and perspectives
10.1136/gutjnl-2019-318843 · ExternalCitation · doi-reference
Peripheral neuropathy in chronic liver disease: clinical, electrodiagnostic, and nerve biopsy findings
10.1136/jnnp.35.1.22 · ExternalCitation · doi-reference
Autonomic neuropathy in patients with hepatic cirrhosis
10.1136/pmj.79.933.408 · ExternalCitation · doi-reference
Intracerebral Hemorrhage
10.1159/000542566 · ExternalCitation · doi-reference
Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?
10.1161/jaha.116.005307 · ExternalCitation · doi-reference
Discharge Disposition After Stroke in Patients With Liver Disease
10.1161/strokeaha.116.016016 · ExternalCitation · doi-reference
Management of Stroke in Patients With Chronic Liver Disease: A Practical Review
10.1161/strokeaha.123.043011 · ExternalCitation · doi-reference
Neuropsychiatric symptoms as the presenting feature of acquired hepatocerebral degeneration
10.1177/0004867414531079 · ExternalCitation · doi-reference
Prothrombin Complex Concentrate Use in Intracranial Hemorrhage Patients With Cirrhosis Not on Prior Anticoagulation
10.1177/08850666211012650 · ExternalCitation · doi-reference
Benzodiazepines and risk for hepatic encephalopathy in patients with cirrhosis and ascites
10.1177/2050640617727179 · ExternalCitation · doi-reference
Liver Transplantation Reverses Hepatic Myelopathy in 2 Children With Hepatitis A Infection
10.1177/2329048x20983763 · ExternalCitation · doi-reference
Hepatic myelopathy neurological complication of chronic liver disease: two case reports
10.1186/s13256-024-04495-2 · ExternalCitation · doi-reference
Neurologic Manifestations of Hepatic and Gastrointestinal Disease
10.1212/cont.0000000000001666 · ExternalCitation · doi-reference
Reflex inhibition of electrically induced muscle cramps in hypohydrated humans
10.1249/mss.0b013e3181c0647e · ExternalCitation · doi-reference
Spontaneous remission of hepatic myelopathy in a patient with alcoholic cirrhosis: A case report
10.12998/wjcc.v10.i30.11172 · ExternalCitation · doi-reference
Delayed Onset Acute Subdural Hematoma after Burr Hole Drainage in a Patient with Chronic Subdural Hematoma and Liver Cirrhosis
10.13004/kjnt.2021.17.e15 · ExternalCitation · doi-reference
Decreased serum hepcidin concentration correlates with brain iron deposition in patients with HBV-related cirrhosis
10.1371/journal.pone.0065551 · ExternalCitation · doi-reference
A Mimic of Hepatic Encephalopathy: Two Cases of Cryptococcal Meningitis in North America
10.14218/jcth.2019.00005 · ExternalCitation · doi-reference
Liver Transplantation Reverses Hepatic Myelopathy in the Decompensated Phase of Cirrhosis: Case Report and Literature Review
10.14218/jcth.2023.00487 · ExternalCitation · doi-reference
Pickle Juice Intervention for Cirrhotic Cramps Reduction: The PICCLES Randomized Controlled Trial
10.14309/ajg.0000000000001781 · ExternalCitation · doi-reference
Pathomechanisms in hepatic encephalopathy
10.1515/hsz-2021-0168 · ExternalCitation · doi-reference
Acquired chronic hepatocerebral degeneration (CAHD)—Simulation of parkinsonism, secondary to chronic liver disease
10.17235/reed.2024.10535/2024 · ExternalCitation · doi-reference
Hepatic myelopathy improved by embolization of spontaneous portosystemic shunt and partial splenic artery embolization—Literature review
10.17235/reed.2025.11451/2025 · ExternalCitation · doi-reference
The predictive role of autonomic neuropathy in pre- and post-liver transplantation outcomes: a systematic review and meta-analysis
10.20524/aog.2024.0905 · ExternalCitation · doi-reference
Retrospective Analysis of Risk Factors for Recurrent Chronic Subdural Hematoma
10.21129/nerve.2016.2.2.54 · ExternalCitation · doi-reference
The pathophysiology of thrombocytopenia in chronic liver disease
10.2147/hmer.s74612 · ExternalCitation · doi-reference
Sleep disturbances in patients with liver cirrhosis: prevalence, impact, and management challenges
10.2147/nss.s186665 · ExternalCitation · doi-reference
Intracerebral hemorrhage in patients with chronic liver disease
10.2176/nmc.52.181 · ExternalCitation · doi-reference
Brain surgery in patients with liver cirrhosis
10.3171/2012.4.jns111338 · ExternalCitation · doi-reference
Hepatic Myelopathy: Case Report of an Unusual MRI Finding
10.3174/ng.1700019 · ExternalCitation · doi-reference
Multiple cerebral abscesses in decompensated cirrhosis of liver as a mimicker of hepatic encephalopathy: A case report
10.32677/ijcr.2018.v04.i04.017 · ExternalCitation · doi-reference
Untangling the Manganese-α-Synuclein Web
10.3389/fnins.2016.00364 · ExternalCitation · doi-reference
Comprehensive Overview of Sleep Disorders in Patients with Chronic Liver Disease
10.3390/brainsci11020142 · ExternalCitation · doi-reference
Nutritional Management in Liver Cirrhosis: A Combined Systematic Review and Observational Study
10.3390/diseases13090278 · ExternalCitation · doi-reference
Ammonia and the Muscle: An Emerging Point of View on Hepatic Encephalopathy
10.3390/jcm11030611 · ExternalCitation · doi-reference
Frailty and Sleep Disorder in Chronic Liver Diseases
10.3390/life10080137 · ExternalCitation · doi-reference
Liver Cirrhosis: Evolving Definitions, and Recent Advances in Diagnosis, Prevention and Management
10.3390/livers5030028 · ExternalCitation · doi-reference
Autonomic and sensory nerve dysfunction in primary biliary cirrhosis
10.3748/wjg.v10.i20.3039 · ExternalCitation · doi-reference
Management of surgical splenorenal shunt-related hepatic myelopathy with endovascular interventional techniques
10.3748/wjg.v18.i47.7104 · ExternalCitation · doi-reference
Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy
10.3748/wjg.v19.i1.26 · ExternalCitation · doi-reference
[Analysis of clinical characteristics, prognosis, and influencing factors of hepatic myelopathy]
10.3760/cma.j.cn112137-20240704-01512 · ExternalCitation · doi-reference
Hepatic encephalomyelopathy: a complication following liver cirrhosis caused by Budd-Chiari syndrome and HBV
10.3855/jidc.3052 · ExternalCitation · doi-reference
Oral branched-chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with meta-analyses of randomized controlled trials
10.3945/jn.113.174375 · ExternalCitation · doi-reference
Liver disease severity is poorly related to the presence of restless leg syndrome in patients with cirrhosis
10.4103/0028-3886.263171 · ExternalCitation · doi-reference
Restless leg syndrome in patients with liver cirrhosis: Waiting for the shoe to drop
10.4103/0028-3886.263218 · ExternalCitation · doi-reference
Supratentorial
10.4103/aian.aian_233_18 · ExternalCitation · doi-reference
Management of restless legs syndrome in chronic liver disease: A challenge for the correct diagnosis and therapy
10.4254/wjh.v10.i3.379 · ExternalCitation · doi-reference
CLIF-SOFA and CLIF-C scores for the prognostication of acute-on-chronic liver failure and acute decompensation of cirrhosis: A systematic review
10.4254/wjh.v14.i12.2025 · ExternalCitation · doi-reference
Acrocyanosis A Manifestation of Autonomic Dysfunction in Chronic Liver Disease-Case Report
10.47363/jghr/2022(3)136 · ExternalCitation · doi-reference
Psychometric hepatic encephalopathy score (PHES)—when, how, why, and why not: a guide for the unfamiliar
10.5114/pg.2024.145382 · ExternalCitation · doi-reference
Increased occurrence of brain abscesses in cirrhotic patients: A population-based 3-year follow-up study
10.5152/tjg.2017.6374 · ExternalCitation · doi-reference
Comparing Frequency of Cardiovascular Autonomic Neuropathy in Diabetic Cirrhotic with Non-Diabetic Cirrhotic Patients
10.54393/pbmj.v5i1.169 · ExternalCitation · doi-reference
Shunt encephalomyelopathy. II. Occurrence of permanent myelopathy
10.7326/0003-4819-53-1-53 · ExternalCitation · doi-reference
Hepatic Myelopathy: A Rare Complication of Chronic Liver Failure Treated Conservatively Without Liver Transplantation
10.7326/aimcc.2024.0940 · ExternalCitation · doi-reference
Manganese, a Likely Cause of ‘Parkinson’s in Cirrhosis’, a Unique Clinical Entity of Acquired Hepatocerebral Degeneration
10.7759/cureus.10448 · ExternalCitation · doi-reference
Hepatic Encephalopathy and Treatment Modalities: A Review Article
10.7759/cureus.28016 · ExternalCitation · doi-reference
Bacterial Meningitis Associated With Spontaneous Bacterial Peritonitis Caused by Escherichia coli in a Patient With Alcoholic Liver Cirrhosis
10.7759/cureus.77937 · ExternalCitation · doi-reference
Recent Updates on Acquired Hepatocerebral Degeneration
10.7916/d8tb1k44 · ExternalCitation · doi-reference